DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

Issue S 1 · Volume 30 · February 2004 DOI: 10.1055/s-002-3229 Expanded Role of Low-Molecular-Weight Heparins in Hematology and Oncology Editor in Chief Eberhard F Mammen M.D., Guest Editors Debra Hoppensteadt Ph.D. Rodger L Bick M.D. Ph.D. Jawed Fareed Ph.D.

PREFACE

31
Sutor, Anton Heinz; Chan, Anthony K. C.; Massicotte, Patricia: Low-Molecular-Weight Heparin in Pediatric Patients
49
Hoppensteadt, Debra A.; Willows, Louise; Leitz, Helen; Nicolaides, Andrew; Fareed, Jawed: Laboratory Analysis of Blood Samples from Patients Treated with Tinzaparin
57
Walenga, Jeanine M.; Jeske, Walter P.; Prechel, M. Margaret; Bakhos, Mamdouh: Newer Insights on the Mechanism of Heparin-Induced Thrombocytopenia
69
Walenga, Jeanine M.; Jeske, Walter P.; Prechel, M. Margaret; Bacher, Peter; Bakhos, Mamdouh: Decreased Prevalence of Heparin-Induced Thrombocytopenia with Low-Molecular-Weight Heparin and Related Drugs
81
Messmore, Harry L.; Wehrmacher, William H.; Coyne, Erwin; Fareed, Jawed: Heparin to Pentasaccharide and Beyond: The End Is Not in Sight
89
Fareed, Jawed; Ma, Qing; Florian, Michelle; Maddineni, Jyothi; Iqbal, Omer; Hoppensteadt, Debra A.; Bick, Rodger L.: Differentiation of Low-Molecular-Weight Heparins: Impact on the Future of the Management of Thrombosis
105
Hoppensteadt, Debra A.; Fareed, Jawed; Bick, Rodger L.: Epilogue